His­toric drug pric­ing re­forms pass; Pfiz­er ac­quires GBT; The long search for non-opi­oid pain drugs; and more

10 hours ago
Weekly

House pass­es his­toric drug pric­ing re­forms, lin­ing up decades-in-the-mak­ing win for Biden and De­moc­rats

23 hours ago
Law

Do phar­ma TV and so­cial ads work? Phar­ma mar­ket­ing agen­cies adopt­ing new tech so­lu­tions to find out

Yesterday
Pharma
Marketing

Pear Ther­a­peu­tics touts Q2 growth while scal­ing back full-year goals and chop­ping 9% of staff

Yesterday
Pharma

Paving the way for Mer­ck­'s buy­out, Seagen los­es ar­bi­tra­tion dis­pute with Dai­ichi over ADC tech

Yesterday
Pharma
Law

FDA ap­proves sec­ond in­di­ca­tion for As­traZeneca and Dai­ichi's En­her­tu in less than a week

Yesterday
Pharma
FDA+

CSL brings Se­qirus, Vi­for un­der par­ent um­brel­la brand in iden­ti­ty re­vamp

Yesterday
Pharma
Marketing

‘The place­bo caught up’: Months af­ter di­a­bet­ic nerve pain fail, Aptinyx sees an­oth­er pain tri­al fall through

Yesterday
R&D

Gold for adults, sil­ver for in­fants: Pfiz­er's Pre­vnar 2.0 head­ed to FDA months af­ter Mer­ck­'s green light

Yesterday
R&D
Pharma

Blast­ing 'spec­u­la­tive com­men­tary,' GSK of­fers up­date on Zan­tac lit­i­ga­tion and vows to 'vig­or­ous­ly de­fend it­self'

Yesterday
Pharma
Law

No­var­tis re­ports two pa­tient deaths af­ter treat­ment with Zol­gens­ma

Yesterday
Pharma

Sanofi, GSK, Ha­le­on see stock prices dip and dive amid lit­i­ga­tion for re­called heart­burn drug

2 days ago
Pharma
Law

Bellde­grun-backed re­al es­tate de­vel­op­ment group blue­prints a new biotech cam­pus — this time in Boul­der

2 days ago
R&D

Astel­las an­nu­al can­cer prize goes to mo­bile re­port­ing app to bridge care gaps

2 days ago
Pharma
Marketing

Sim­ba Gill heads back to Flag­ship af­ter sev­en-year run as Evelo CEO

2 days ago
People

Amid Roche and Sanofi's oral SERD set­backs, Menar­i­ni gets speedy re­view at FDA

2 days ago
Pharma
FDA+

Cit­ing 'chal­leng­ing eco­nom­ic en­vi­ron­ment,' PhI­II-ready mi­cro­bio­me biotech lays off 20% of staffers

2 days ago
People

Cerev­el takes the pub­lic of­fer­ing route, with a twist — rais­ing big mon­ey thanks to ri­val da­ta

2 days ago
Financing

Hori­zon read­ies kids and fam­i­lies for back to school with week­long ac­tiv­i­ties around rare dis­ease cysti­nosis

3 days ago
Pharma
Marketing

EMA is­sues warn­ing of IVF drug short­age due to man­u­fac­tur­ing is­sues

3 days ago
Pharma
Manufacturing

Catal­ent ac­quires North Car­oli­na CD­MO for $475M, boost­ing oral solids work

3 days ago
Deals
Manufacturing

Phar­mas spend mil­lions on di­a­betes ad­ver­tis­ing, but few pa­tients can re­call brand names — sur­vey

3 days ago
Pharma
Marketing

Feud be­tween two biotechs left near­ly 12M dos­es of mon­key­pox an­tivi­ral on the ta­ble

3 days ago
Pharma

One of 2021's star biotech play­ers flags an­oth­er big set­back for the pipeline

3 days ago
R&D
1234 Next page Last page